Rio de Janeiro, Brazil – November 17-20, 2026
TB Alliance at the Union Conference
The Union World Conference on Lung Health brings together researchers, health workers, advocates, and communities working toward a future free from TB. This year in Rio de Janeiro, TB Alliance and partners will share research exploring the next generation of TB treatments, discuss how countries can accelerate access to new tools, and bring new voices into the global conversation about TB. Explore the updates below and use this toolkit to help share the science, stories, and partnerships driving progress.

Advancing the next generation of TB treatments
Shorter, simpler, and more effective treatments could transform the lives of people affected by TB. At this year’s conference, TB Alliance and collaborators will present research on sorfequiline, an investigational medicine being developed as a potential foundation for future TB treatments. Presentations will include follow-up findings from the NC-009 clinical trial, research informing more inclusive drug development, and studies examining drug resistance. Researchers will also explore long-acting injectable treatment approaches and early scientific discoveries that could expand future treatment options.
Turning innovation into access
Developing a new treatment is only part of the work. Ensuring it reaches people who need it requires country leadership, locally generated evidence, strong health systems, and meaningful community engagement. In Rio, TB Alliance will join partners to discuss lessons from introducing shorter, all-oral TB treatments and opportunities to overcome the technical and policy barriers that can delay access. These conversations will explore how countries’ experiences and priorities can shape a faster, more equitable path from scientific progress to everyday care.


Introducing the TB Alliance Creator Collective
The stories and science of TB deserve an audience far beyond the conference halls. TB Alliance’s inaugural Creator Collective brings together seven creators with backgrounds spanning science, health communication, and lifestyle content to help reach new audiences. In Rio, they will connect with researchers, advocates and people affected by TB, and visit a local TB clinic through Brazilian partner CEDAPS. They will also share their expertise through a panel and hands-on workshop with Fast Track the Cure, exploring how digital storytelling can make TB information more accessible, relevant, and engaging.
Suggested Social Media Posts
- What will it take to turn the next generation of TB research into better care? At this year’s #UnionConf in Rio, follow TB Alliance and partners for updates on treatment research, community perspectives, and country-led efforts to accelerate access. Explore the programme: https://www.tballiance.org/tb-alliance-at-the-2026-union-conference/ #EndTB #Tuberculosis #GlobalHealth
- A scientific breakthrough is really only the beginning of a much longer journey. Developing better TB treatments must go hand in hand with preparing health systems, supporting health workers, and working with communities to make those treatments available and accessible. That connection belongs at the heart of conversations happening at this year’s #UnionConf in Rio de Janeiro 🇧🇷 #EndTB
- Seven creators. New perspectives. More conversations about TB. Meet the inaugural TB Alliance Creator Collective, bringing the people and science of TB to audiences beyond the conference halls. Follow their journey to Rio: https://www.tballiance.org/tb-alliance-launches-creator-collective-to-highlight-tb-in-the-global-conversation/ #UnionConf #EndTB
- At the 2026 #UnionConf in Rio de Janeiro, researchers will share post-treatment follow-up from the NC-009 Phase 2 clinical trial, helping to build understanding of new, shorter treatment approaches. Find out more about what TB Alliance’s research presented at this year’s conference: https://www.tballiance.org/tb-alliance-at-the-2026-union-conference/ #EndTB #Tuberculosis
- 🇧🇷 TB Alliance is heading to Rio for #UnionConf! From new research on the next generation of TB treatments to discussions on accelerating access and a digital advocacy workshop with our inaugural Creator Collective, explore what TB Alliance and partners are bringing to this year’s conference. See our presentations and activities: https://www.tballiance.org/tb-alliance-at-the-2026-union-conference/ #EndTB
- Who helps you make sense of science? The TB Alliance Creator Collective connects creators with TB researchers, advocates and people affected by the disease – helping bring these conversations to audiences through voices they already know. Meet the Collective: https://www.tballiance.org/tb-alliance-launches-creator-collective-to-highlight-tb-in-the-global-conversation/ #UnionConf #EndTB
- How can a social media post become a starting point for TB advocacy? Join @TB Alliance, @Fast Track the Cure and the Creator Collective for “From Visibility to Impact” – a panel and practical workshop on digital advocacy. November 18 · 11:00–13:15 · Oceania X, Rio time. Details: https://www.tballiance.org/tb-alliance-at-the-2026-union-conference/ #UnionConf
- As the global TB community gathers in Brazil 🇧🇷 let’s make space to learn from the country’s researchers, health workers, advocates, and communities. What can their experience teach us about connecting innovation with care? And how can international partnerships support the priorities they identify? #UnionConf #EndTB #GlobalHealth
- TB research must address the needs of all people. At #UnionConf, researchers will present nonclinical reproductive safety research on investigational treatments, helping inform efforts to develop more inclusive clinical trials. Find out more about TB Alliance’s research and presentations in Rio de Janeiro: https://www.tballiance.org/tb-alliance-at-the-2026-union-conference/ #EndTB
- Could treatment research help bridge the divide between drug-sensitive and drug-resistant TB? A subanalysis of NC-009 that will be presented at this year’s #UnionConf will explore a three-drug regimen in participants with drug-sensitive TB. Find out more about the session: https://www.tballiance.org/tb-alliance-at-the-2026-union-conference/ #EndTB
- Developing better TB treatments means understanding when treatment falls short. At #UnionConf, researchers will examine bacteriologic failures, recurrences, and drug resistance from the NC-009 Phase 2 clinical trial. Explore this research and more that will be presented at the conference: https://www.tballiance.org/tb-alliance-at-the-2026-union-conference/ #EndTB